On Aug. 5, Cardinal Health
- Cardinal's performance picked up steam over the second half of the year.
- The company lowered its outlook for FY 2006, however.
- Cardinal was on Philip Durell's watch list last year.
(Figures in millions, except per-share data)
Income Statement Highlights (What's this?)
|
Avg. Est. |
Q4 2005 |
Q4 2004 |
% Change |
|
|---|---|---|---|---|
|
Sales |
$19,260 |
$19,457 |
$16,922 |
+15.0% |
|
Net Profit |
-- |
$287 |
$394 |
-27.0% |
|
EPS |
$ 0.89 |
$0.66 |
$0.90 |
-26.7% |
Margin Checkup (What's this?)
|
Q4 2005 |
Q4 2004 |
Change |
|
|---|---|---|---|
|
Gross Margin |
7.06% |
7.23% |
-0.18% |
|
Op. Margin |
2.73% |
3.47% |
-0.73% |
|
Net Margin |
1.48% |
2.33% |
-0.85% |
Balance Sheet Highlights (What's this?)
|
Assets |
Q4 2005 |
Q4 2004 |
% Change |
|---|---|---|---|
|
Cash+ ST Invest. |
$1,512 |
$1,096 |
+37.9% |
|
Inventory |
$7,392 |
$7,471 |
-1.1% |
|
Accounts Rec. |
$3,451 |
$3,433 |
+0.5% |
|
Liabilities |
Q4 2005 |
Q4 2004 |
% Change |
|---|---|---|---|
|
Long-Term Debt |
$2,335 |
$2,835 |
-17.6% |
|
Accounts Pay. |
$7,628 |
$6,432 |
+18.6% |
Cash Flow Highlights (What's this?)
|
Q4 2005 |
Q4 2004 |
% Change |
|
|---|---|---|---|
|
Cash From Ops |
$806 |
$1,289 |
-37.5% |
|
Capital Expend. |
$280 |
$138 |
+102.6% |
|
Free Cash Flow |
$526 |
$1,151 |
-54.3% |
Related Companies:
-
Priority Healthcare Corp
(NASDAQ:PHCC) -
McKesson Corp
(NYSE:MCK) -
Owens and Minor
(NYSE:OMI) -
Cantel
Medical Corp
(NYSE:CMN) -
AmerisourceBergen Corp
(NYSE:ABC) -
AXCAN PHARMA
(NASDAQ:AXCA)
Related Foolishness:
At Motley Fool Inside Value, lead analyst Philip Durell keeps his eye on potential value plays like Cardinal Health. Click here to see Philip's recommended companies.
Cantel Medical is a Motley Fool Hidden Gems selection.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.
At the time of publication, John Reeves did not own shares in any of the companies mentioned in this article. Fool rules are here.
